Umoja Biopharma, Inc.
2 known investors
Umoja Biopharma develops in vivo CAR T cell therapies for cancer treatment using its VivoVec platform, which generates CAR T cells directly in patients' bodies. The company operates its own manufacturing facility to produce these cancer immunotherapies.
BiotechDigital HealthMedical Devices